chr5-76716239-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001992.5(F2R):c.-69G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00065 in 1,235,352 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0032 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00029 ( 3 hom. )
Consequence
F2R
NM_001992.5 5_prime_UTR
NM_001992.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.771
Genes affected
F2R (HGNC:3537): (coagulation factor II thrombin receptor) Coagulation factor II receptor is a 7-transmembrane receptor involved in the regulation of thrombotic response. Proteolytic cleavage leads to the activation of the receptor. F2R is a G-protein coupled receptor family member. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 5-76716239-G-A is Benign according to our data. Variant chr5-76716239-G-A is described in ClinVar as [Benign]. Clinvar id is 3038746.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 488 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
F2R | NM_001992.5 | c.-69G>A | 5_prime_UTR_variant | 1/2 | ENST00000319211.5 | ||
F2R | NM_001311313.2 | c.-554G>A | 5_prime_UTR_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
F2R | ENST00000319211.5 | c.-69G>A | 5_prime_UTR_variant | 1/2 | 1 | NM_001992.5 | P1 | ||
F2R | ENST00000505600.1 | c.-69G>A | 5_prime_UTR_variant | 1/2 | 2 | ||||
ENST00000507514.1 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00319 AC: 486AN: 152174Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
486
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000291 AC: 315AN: 1083066Hom.: 3 Cov.: 15 AF XY: 0.000274 AC XY: 143AN XY: 521268
GnomAD4 exome
AF:
AC:
315
AN:
1083066
Hom.:
Cov.:
15
AF XY:
AC XY:
143
AN XY:
521268
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00320 AC: 488AN: 152286Hom.: 4 Cov.: 33 AF XY: 0.00305 AC XY: 227AN XY: 74458
GnomAD4 genome
AF:
AC:
488
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
227
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
F2R-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at